Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGI

Accumulation of [18F]FAPI-74 in biliary system as a potential pitfall in evaluating pancreaticobiliary cancer

Joonhyung Gil, Hongyoon Choi, Jin Chul Paeng, Keon Wook Kang, Jin-Young Jang and Gi Jeong Cheon
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 3034;
Joonhyung Gil
1Department of Nuclear Medicine, Seoul National University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongyoon Choi
2Seoul National University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Chul Paeng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keon Wook Kang
3Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin-Young Jang
4Department of Surgery, Seoul National University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gi Jeong Cheon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

3034

Introduction: Fibroblast activation protein inhibitor (FAPI) analogs are newly introduced PET agents for cancer imaging. As a preliminary result of a human PET study for [18F]FAPI-74, a fluorine-labeled agent, we assessed potential pitfalls in interpreting pancreaticobiliary cancer.

Methods: Fourteen patients who had been diagnosed with pancreas or common bile duct (CBD) cancer were prospectively enrolled (11 for pancreatic cancer and 3 for CBD cancer). [18F]FAPI-74 PET images were acquired 60 min and 120 min after the injection. Images were analyzed by qualitative and quantitative methods. Gallbladder (GB), biliary duct, normal pancreatic parenchyma were organs of interest in quantitative analysis. We regarded accumulation higher than liver uptake as physiologic FAPI accumulation. A volume of interest (VOI) of GB was drawn to include GB in three planes. A relative threshold of 40% of SUVmax was applied to measure FAPI-active-volume (FAV) and Total-lesion-FAPI-uptake (TLF). In both 60-min and 120-min images, three 5 mm spherical VOIs were drawn in each of the biliary duct and pancreas. Average SUVmax and SUVmean of three spherical VOI were used for quantitative analysis. Wilcoxon signed-rank test was used for statistical analysis

Results: [18F]FAPI-74 accumulation in the GB lumen was seen in 7/10 (70%) of pancreas cancer patients and 1/3 (33.3%) of CBD cancer patients. A patient with pancreatic cancer underwent cholecystectomy. [18F]FAPI-74 accumulation in biliary duct was seen in 10/11 (90.9%) and 2/3 (66.7%) of CBD cancer patients. FAPI-uptake in normal pancreas parenchyma was seen in 5/11 (45.4%) of pancreas cancer and 1/3 (33.3%) of CBD cancer patients. All of GB uptake were similar or higher than primary tumor uptake. SUVmax and SUVmean of biliary duct and pancreas were statistically significantly decreased at 120-min. SUVmax, SUVmean, FAV, and TLF of GB were increased at 120-min. FAV and TLF show statistical significance.

Conclusions: [18F]FAPI-74 accumulation in GB, biliary duct, and pancreas could be a pitfall in interpreting images for pancreaticobiliary cancer. The comprehensive interpretation of the accumulation pattern in biliary system through quantitative analysis and delay scan could be required for [18F]FAPI-74 PET imaging.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Accumulation of [18F]FAPI-74 in biliary system as a potential pitfall in evaluating pancreaticobiliary cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Accumulation of [18F]FAPI-74 in biliary system as a potential pitfall in evaluating pancreaticobiliary cancer
Joonhyung Gil, Hongyoon Choi, Jin Chul Paeng, Keon Wook Kang, Jin-Young Jang, Gi Jeong Cheon
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3034;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Accumulation of [18F]FAPI-74 in biliary system as a potential pitfall in evaluating pancreaticobiliary cancer
Joonhyung Gil, Hongyoon Choi, Jin Chul Paeng, Keon Wook Kang, Jin-Young Jang, Gi Jeong Cheon
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3034;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET
  • Google Scholar

More in this TOC Section

  • Comparative study on the diagnostic efficacy of integrated PET / MR and PET / CT in primary liver cancer
  • The potential value of 18F-FDG PET/CT in the indirect prediction of imatinib treatment response of GISTs
  • Relationship of 18F-FDG PET/CT Parameters and CLDN 18.2 Expression Status in Gastric Cancer
Show more GI

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire